{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T05:28:21.669967",
  "document": "Factor-XI-Deficiency.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/train/Factor-XI-Deficiency.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 4,
  "total_validated": 4,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "diseases": [
    {
      "matched_text": "severe form",
      "preferred_label": "Mucopolysaccharidosis type 2, severe form",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:217085",
        "umls": null,
        "mesh": null
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:217085",
          "display": null
        }
      ],
      "context": "can affect individuals of any age and any ethnic group. It is the second most common bleeding disorder to affect women (after von Willebrand disease). The incidence of factor XI deficiency is higher in individuals of Ashkenazi Jewish descent where it is estimated to affect 8% of the population. The severe form of the disorder is estimated to affect approximately 1 in 1,000,000 people in the general population.",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphanet_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "von Willebrand disease",
      "preferred_label": "von Willebrand disease",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:D68.0",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0024574",
        "orpha": null,
        "umls": "UMLS:C0042974",
        "mesh": "MESH:D014842"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0024574",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:D68.0",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:286.4",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:22686",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D014842",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2200682",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C68677",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:128105004",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0042974",
          "display": null
        }
      ],
      "context": "Factor XI deficiency affects males and females in equal numbers. The disorder can affect individuals of any age and any ethnic group. It is the second most common bleeding disorder to affect women (after von Willebrand disease). The incidence of factor XI deficiency is higher in individuals of Ashkenazi Jewish descent where it is estimated to affect 8% of the population. The severe form of the disorder is estimated to affect approximately 1 in 1,000,000 people in the general population.",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "von Willebrand Disease Type 2",
        "von Willebrand Disease Type 1",
        "von Willebrand Disease Type 3"
      ],
      "pubtator_normalized_name": "von Willebrand Diseases",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "Factor XI deficiency",
      "preferred_label": "factor XI deficiency",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0020587",
        "orpha": null,
        "umls": "UMLS:C4321502",
        "mesh": "MESH:D005173"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0020587",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:1386956",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D005173",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2200679",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C131739",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:767713001",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C4321502",
          "display": null
        }
      ],
      "context": "Factor XI deficiency affects males and females in equal numbers. The disorder can affect individuals of any age and any ethnic group. It is the second most common bleeding disorder to affect women (after von Willebrand disease). The incidence of factor XI deficiency is higher in individuals of Ashkenazi Jewish descent",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Factors VIII IX And XI Combined Deficiency of",
        "Familial Multiple Coagulation Factor Deficiency VI"
      ],
      "pubtator_normalized_name": "Factor XI Deficiency",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "bleeding disorder",
      "preferred_label": "bleeding disorder",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0002243",
        "orpha": null,
        "umls": "UMLS:C0019087",
        "mesh": "MESH:D006474"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0002243",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:2213",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:287.9",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:6799",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D006474",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C115221",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0019087",
          "display": null
        }
      ],
      "context": "Factor XI deficiency affects males and females in equal numbers. The disorder can affect individuals of any age and any ethnic group. It is the second most common bleeding disorder to affect women (after von Willebrand disease). The incidence of factor XI deficiency is higher in individuals of Ashkenazi Jewish descent where it is estimated to affect 8% of the population. The severe form of the disorder is estimated to affect approximately 1 in 1,000,000 people in the general",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Bleeding Disorder due to Defective Thromboxane A2 Receptor",
        "Bleeding Disorder Due To P2RY12 Defect"
      ],
      "pubtator_normalized_name": "Bleeding Disorder East Texas Type",
      "enrichment_source": "pubtator3"
    }
  ]
}